A quantitative PCR method to quantify ruminant DNA in porcine crude heparin.
Heparin is a well-known glycosaminoglycan extracted from porcine intestines. Increased vigilance for transmissible spongiform encephalopathy in animal-derived pharmaceuticals requires methods to prevent the introduction of heparin from ruminants into the supply chain. The sensitivity, specificity, and precision of the quantitative polymerase chain reaction (PCR) make it a superior analytical platform for screening heparin raw material for bovine-, ovine-, and caprine-derived material. A quantitative PCR probe and primer set homologous to the ruminant Bov-A2 short interspersed nuclear element (SINE) locus (Mendoza-Romero et al. J. Food Prot. 67:550-554, 2004) demonstrated nearly equivalent affinities for bovine, ovine, and caprine DNA targets, while exhibiting no cross-reactivity with porcine DNA in the quantitative PCR method. A second PCR primer and probe set, specific for the porcine PRE1 SINE sequence, was also developed to quantify the background porcine DNA level. DNA extraction and purification was not necessary for analysis of the raw heparin samples, although digestion of the sample with heparinase was employed. The method exhibits a quantitation range of 0.3-3,000 ppm ruminant DNA in heparin. Validation parameters of the method included accuracy, repeatability, precision, specificity, range, quantitation limit, and linearity.
Specialty/Biotechnology Quality Organization, Pfizer Global Manufacturing, 700 Chesterfield Parkway West, Chesterfield, MO 63017-1732, USA.
Sean P
SP
Concannon
P Brett
PB
Wimberley
Wesley E
WE
Workman
D000818:Animals; D000925:Anticoagulants / Q000737:chemistry*; D002417:Cattle; D004247:DNA / Q000032:analysis* / Q000235:genetics; D004340:Drug Contamination; D006493:Heparin / Q000737:chemistry*; D016133:Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D013045:Species Specificity; D013552:Swine
D000925:Anticoagulants; D006493:Heparin; D004247:DNA